Snowdome supports epigenetic BET inhibitors clinical trial
As today is International Clinical Trials Day (commemorating 20 May 1747, the day on which James Lind started his famous trial comparing treatments for scurvy), Snowdome… Read More

As today is International Clinical Trials Day (commemorating 20 May 1747, the day on which James Lind started his famous trial comparing treatments for scurvy), Snowdome… Read More
Over the last 9 months, Snowdome’s funding efforts have been concentrated on directing just over $1,000,000 into epigenetic treatments for Australians with blood cancers. Snowdome… Read More
In a final analysis of the Peter Mac sponsored Azacitidine/Eltrombopag study, haematologist and research fellow, Dr Michael Dickinson, targets myelodysplastic syndromes and gives us a… Read More
My drive for supporting blood cancer started in November 1998, three weeks after my 27th birthday. One evening at 8.30pm my obstetrician called and wanted… Read More
My dearest Mother Virginia: In September 2009, our dearest mother discovered two hot, red lumps on her leg and showed them to us. We took… Read More
September 18 approaches and it will be three years since my sister Andrea was diagnosed with Diffuse Large B cell lymphoma (stage 4). Andrea was… Read More
“Prepare yourselves for the worst and hope for the best”. These words still echo from Dr Henry Eckhart, the Royal Children’s Hospital senior Haematologist and… Read More
Annette’s journey began with a tooth ache, then a blood test and following a visit to the Emergency department at The Alfred she learned she… Read More